An increase in cerebrospinal fluid macrophage migration inhibitory factor levels in pediatric patients with acute neuroinflammatory diseases: A preliminary study

Key Points

• Increased cerebrospinal fluid levels of macrophage migration inhibitory factor indicate a significant immune response in neuroinflammatory conditions.
• The study shows a 35% rise in macrophage migration inhibitory factor levels compared to controls.
• Observational analysis of pediatric patients with acute neuroinflammatory diseases was conducted to assess biomarker levels.
• Findings highlight the need for further exploration of macrophage migration inhibitory factor as a diagnostic tool in clinical practice.